Correlation Between Innovative Medical and Chinese Universe

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovative Medical and Chinese Universe at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovative Medical and Chinese Universe into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovative Medical Management and Chinese Universe Publishing, you can compare the effects of market volatilities on Innovative Medical and Chinese Universe and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovative Medical with a short position of Chinese Universe. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovative Medical and Chinese Universe.

Diversification Opportunities for Innovative Medical and Chinese Universe

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Innovative and Chinese is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Innovative Medical Management and Chinese Universe Publishing in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chinese Universe Pub and Innovative Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovative Medical Management are associated (or correlated) with Chinese Universe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chinese Universe Pub has no effect on the direction of Innovative Medical i.e., Innovative Medical and Chinese Universe go up and down completely randomly.

Pair Corralation between Innovative Medical and Chinese Universe

Assuming the 90 days trading horizon Innovative Medical Management is expected to generate 3.32 times more return on investment than Chinese Universe. However, Innovative Medical is 3.32 times more volatile than Chinese Universe Publishing. It trades about 0.02 of its potential returns per unit of risk. Chinese Universe Publishing is currently generating about 0.05 per unit of risk. If you would invest  895.00  in Innovative Medical Management on September 2, 2024 and sell it today you would lose (6.00) from holding Innovative Medical Management or give up 0.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Innovative Medical Management  vs.  Chinese Universe Publishing

 Performance 
       Timeline  
Innovative Medical 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.
Chinese Universe Pub 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chinese Universe Publishing has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Chinese Universe is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Innovative Medical and Chinese Universe Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovative Medical and Chinese Universe

The main advantage of trading using opposite Innovative Medical and Chinese Universe positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovative Medical position performs unexpectedly, Chinese Universe can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chinese Universe will offset losses from the drop in Chinese Universe's long position.
The idea behind Innovative Medical Management and Chinese Universe Publishing pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.